SlideShare a Scribd company logo
1 of 4
Download to read offline
1
BFSI
Yes Bank
Yes Bank reported tepid set of numbers which were marginally below our estimates. While NII grew by 13.1% YoY to
INR 7453 mn, profit grew by 9.6% to INR 4395 mn dented largely by 3.7% decline in non interest income and 25.1% surge in
operating expenses (driven by advertisement expenses of ~INR 230 mn relating to IPL sponsorship). Asset quality continued
to remain robust with PCR of 78.4% and loan impaired ratio of mere 0.52%, which is amongst the best in the industry.
We change our rating from BUY to HOLD on the stock with a target of INR 572.
Corporate banking driving advances
Advances grew by 23.2% to INR 590 bn led by 31.6% surge in
Corporatebankingsegment (contribution+440bpsto68.7%).Retail
bankingsegmentcontributing16.8%alsoclockedagrowthof23.2%
YoY to INR 99 bn. The bank remained cautious in lending to mid-
sized corporate as advances in this segment declined by 4.0%. The
customerassetsgrewby16.4%(<20%forfourthconsecutivequarter)
to INR 713 bn due to slower traction in credit substitute segment,
proportion of which declined by 454 bps to 17.3%. We expect the
loan book to grow at 21.4% CAGR over FY14-16E.
Traction in CASA continues
CASA traction continued with CASA ratio improving by 213 bps to
22.3% driven by 1.4x increase in savings deposits. Additionally
YBL has started focusing on retail CA to drive CA deposits and has
added 200-250 retail CA sales force. Overall deposits grew by
16.6% to INR 761 bn led by 29.0% surge in CASA deposit to INR 170
bn. Increasing traction in savings deposits coupled with increasing
branch penetration and renewed focus towards building retail
liability franchise would aid YBL to improve its CASA ratio by ~1-
1.5% each quarter. We expect deposit to grow at 16.6% CAGR
over FY14-16E driven by 29.9% CAGR in CASA deposits, resulting
CASA ratio of 27.3% in FY16.
NIMs flat at 3.0%
NIMs remained flat at 3.0% as both yields on advances & cost of
funds increased sequentially by 10 bps each to 12.5% & 8.5%
respectively in Q1FY15. We expect NIMs to improve by over 10
bps led by improvement in yields (supported by recent capital
issuance) and moderating cost of funds (on the back of improving
CASA ratio and expected softening in wholesale rates).
Decline in Non-Interest income after 14 quarters
NOI declined by 3.7% (for the first time after 14 quarters) to INR
4256 mn largely owing to one time monetization of bond gains
Shareholding (%) Jun-14
Promoters 22.22
FIIs 45.60
DIIs 20.44
Others 11.74
Relative Prince Performance
July 24, 2014 RESULTUPDATE-Q1FY15
amounting to INR 950 mn amidst favorable debt market
environment in Q1FY14. Transaction banking segment reported a
growth of 59.0% to INR 1402 mn on the back of enhanced cross
selling of products to customers. Retail banking fees segment
grew 43.8% to INR 525 mn albeit on a low base, which is in line
with its strategy of building granularity in fee income. Growth in
Financial advisory segment improved by 37.5% to INR 1975 mn.
Financial Market segment bore the brunt as it declined sharply
by 79.7% owing to INR 450 mn loss on swap position taken in
earlier quarters to protect the investment portfolio against a rise
in interest rates.
Asset quality continues to remain robust
Asset quality remained among the best in the industry with
impaired loan ratio of mere 0.52% largely owing to its stringent
risk management system. Restructured book stood at INR 1131
mn (0.19% of advances). Slippages, recoveries/upgrades and
write-offs stood at INR 1150 mn, INR 820 mn and INR 100 mn
respectively. Strong PCR of 78.1% in addition to countercyclical
buffer of INR 2.4 bn (0.4% of advances) provides comfort of asset
quality front.
Outlook & Valuation
YBL is one of our preferred plays in private banking sector due to
its expanding corporate book, strengthening balance sheet,
diversified fee income and superlative return ratios. Its strategy
of shifting product mix in favour of high yielding segments coupled
with continued traction in CASA deposit mobilization will drive
the growth of YBL. Best asset quality in the industry coupled with
loan impaired ratio of mere 0.52% provides addition comfort.
Recent capital raising in addition to expected economic revival
lends comfort to banks valuation. We change our rating from BUY
to HOLD on the stock with a target of INR 572, which implies 1.79x
FY16E P/ABV.
Key Data
BSE Code 532648
NSE Code YESBANK
Bloomberg Code YES IN
Reuters Code YESB.BO
Shares O/S (mn) 415.20
Face Value 10
Mcap (INR bn) 222.82
52 Week H/L 588.00/216.10
2W Avg. Qty, NSE 3721561
Free Float (INR bn) 173.31
Beta 2.43
Y/E March (INR mn) FY13 FY14 FY15E FY16E
Interest income 82940 99814 113024 133005
Interest Expended 60752 72651 81674 94912
Net interest income 22188 27163 31350 38093
Growth (%) 37.33% 22.42% 15.41% 21.51%
NIM (%) 2.85% 2.91% 3.01% 3.13%
APAT 13007 16178 19720 23369
Growth (%) 33.06% 24.34% 21.89% 18.50%
EPS (INR) 36.28 44.86 47.50 56.28
P/E 11.81 9.22 11.30 9.53
P/ABV 2.65 2.10 1.94 1.68
Net NPA 0.01% 0.05% 0.07% 0.06%
RoA 1.51% 1.55% 1.66% 1.67%
RoE 24.82% 25.03% 21.14% 18.81%
Dividend Yield 1.40% 1.93% 1.68% 2.05%
Sensex: 26147 CMP:INR537 Target: INR 572
Rohit Agarwal
rohit.agarwal@spagroupindia.com
Ph. No. 91 33 40114800/ 839
40
60
80
100
120
140
Jul-13
Aug-13
Sep-13
Oct-13
Nov-13
Dec-13
Jan-14
Feb-14
Mar-14
Apr-14
May-14
Jun-14
Jul-14
Yes Bank Sensex
2
BFSI
Other Highlights
• C/I ratio has deteriorated sequentially by 338 bps to 45.0%
owing to higher advertisement cost relating to IPL sponsorship
amounting to INR 230 mn and muted growth in income.
• Provision during the quarter stood at INR 237 mn. Break-up -
a) INR 400 mn for standard assets - INR 210 mn for general
loss & INR 190 mn for unhedged forex currency exposure as
per RBI guidelines (YBL has assessed clients to unhedged foreign
currency at INR 760 mn overall, which it has spread over four
quarters of FY15. This is however expected to decline as actual
unhedged forex will likely be lower), b) INR 120 mn as counter
cyclical buffer provisions, c) INR 180 mn for NPAs and d) write
back of INR 460 mn of investment depreciation (Rates have
decline in Q1 and hence losses have reversed)
• CAR has improved to 18.0% with Tier I being at 12.6% post
recent capital issuance of $ 500 mn, which will aid in
maintaining growth for next couple of years.
Quarterly Financials
Particulars(INRmn) Q1FY15 Q4FY14 Q3FY14 Q2FY14 Q1FY14 YoY% QoQ%
InterestIncome 26796 25681 25141 25013 23979 11.75% 4.34%
InterestExpenses 19343 18485 18487 18292 17388 11.24% 4.64%
NetInterestIncome 7453 7196 6655 6721 6591 13.08% 3.58%
NetInterestMargin(%) 3.00 3.00 2.90 2.90 3.00 - -
OtherIncome 4256 4455 3879 4461 4421 -3.72% -4.47%
TotalIncome 11710 11651 10533 11182 11012 6.34% 0.50%
TotalOperatingExpenses 5267 4847 4387 4053 4212 25.05% 8.68%
EmployeeExpenses 2247 2038 1941 1853 2012 11.71% 10.25%
Otheroperatingexpenses 3020 2808 2446 2200 2200 37.25% 7.53%
OperatingProfit 6442 6804 6147 7129 6800 -5.25% -5.32%
CosttoIncomeRatio(%) 44.98% 41.60% 41.64% 36.25% 38.25% (673bps) (338bps)
Provisions&Contingencies 237 723 133 1791 970 -75.52% -67.16%
ProvisionforTaxes 1810 1779 1858 1626 1821 -0.61% 1.73%
NetProfit 4395 4302 4156 3711 4008 9.64% 2.15%
EPS 10.60 11.93 11.53 10.30 11.14 -4.90% -11.17%
Equity 4147 3606 3606 3604 3597 15.29% 15.00%
GNPA 1980 1749 1958 1321 1049 88.68% 13.17%
NNPA 428 261 423 194 121 254.39% 64.21%
%GNPA 0.33 0.31 0.39 0.28 0.22 11bps 2bps
%NNPA 0.07 0.05 0.08 0.04 0.03 4bps 2bps
RoA(Annualised) 1.60 1.60 1.60 1.50 1.60 - -
Source:Company, SPA Research
De-regulation proving to be game changer
10.1% 10.4% 11.2%
12.6% 12.5%
20.2% 20.4% 20.9%
22.0% 22.3%
0%
5%
10%
15%
20%
25%
Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15
Saving Deposit CASA Ratio
NIMsrecouping back to 3%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
14.0%
Q4FY13 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15
2.8%
2.9%
3.0%
3.1%
CoF YoA NIM
Well-distributed fee franchise
39.3% 40.3%
18.2% 12.1% 8.3%
32.4% 27.8%
42.0%
39.5% 46.4%
8.2% 11.6%
11.4% 12.3%
19.9% 20.3% 28.4% 30.0% 32.9%
18.3%
0%
20%
40%
60%
80%
100%
120%
Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15
Financial Markets Financial Advisory
Retail Banking Transaction Banking
Best asset qualityin the industry
0.22
0.28
0.33
0.03 0.04
0.08
0.05 0.07
0.39
0.31
0.00
0.10
0.20
0.30
0.40
0.50
Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15
GNPA (%) NNPA (%)
3
BFSI
Financials
Income StatementY
Y/E March (INR mn) FY13 FY14 FY15E FY16E
Interest income 82940 99814 113024 133005
Growth (%) 31.50% 20.34% 13.24% 17.68%
Interest Expended 60752 72651 81674 94912
Net interest income 22188 27163 31350 38093
Growth (%) 37.33% 22.42% 15.41% 21.51%
Other Income 12574 17216 21520 25393
Net Income 34762 44378 52869 63487
Operating Expenditure 13345 17499 20628 24951
Operating Income 21417 26880 32241 38535
Provisions & Contingencies 2160 3617 3453 4169
PBT 19257 23263 28789 34366
Tax 6251 7085 9068 10997
PAT 13007 16178 19720 23369
APAT 13007 16178 19720 23369
Growth (%) 33.06% 24.34% 21.89% 18.50%
EPS (INR) 36.28 44.86 47.50 56.28
Balance Sheet
Y/E March (INR mn) FY13 FY14 FY15E FY16E
SOURCES OF FUNDS
Equity Share Capital 3586 3606 4152 4152
Reserves 54491 67611 111239 128911
Total Shareholders Funds 58077 71217 115391 133063
Total Deposits 669556 741920 851724 1009293
Growth (%) 36.22% 10.81% 14.80% 18.50%
Borrowings 209222 213143 245114 294137
Other Liabilities & Provisions 54187 63878 70265 73779
Total Liabilities 991041 1090158 1282495 1510272
APPLICATION OF FUNDS
Current Assets 40658 58917 95805 123020
Investments 429760 409504 450454 495499
Advances 469996 556330 667596 819807
Growth (%) 23.72% 18.37% 20.00% 22.80%
Fixed Assets 2295 2935 3043 3069
Other Assets 48332 62473 65597 68877
Total Assets 991041 1090158 1282495 1510272
Key Ratios
Y/E March (INR mn) FY13 FY14 FY15E FY16E
Per Share Data (INR)
EPS 36.28 44.86 47.50 56.28
BVPS 161.94 197.48 277.92 320.48
ABVPS 161.75 196.76 276.87 319.26
DPS 6.00 8.00 9.00 11.00
Profitability Ratios
Yield on Advances 12.79% 12.80% 12.82% 12.86%
Cost of Deposits 10.46% 10.29% 10.25% 10.20%
Net Interest Margin 2.85% 2.91% 3.01% 3.13%
RoA 1.51% 1.55% 1.66% 1.67%
RoE 24.82% 25.03% 21.14% 18.81%
Balance Sheet Ratios
Credit/Deposit Ratio 70.20% 74.99% 78.38% 81.23%
Investment/Deposit Ratio 64.19% 55.20% 52.89% 49.09%
CASA Ratio 18.95% 22.03% 25.91% 27.33%
Capital Adequacy Ratio (CAR) 18.30% 14.40%* 17.40% 16.30%
Tier I 9.50% 9.80% 11.30% 10.20%
Aseet Quality Ratios
Gross NPA 0.20% 0.31% 0.39% 0.43%
Net NPA 0.01% 0.05% 0.07% 0.06%
Provision Coverage Ratio 92.60% 85.10% 85.86% 82.43%
Slippage Ratio 0.57% 0.78% 0.85% 0.82%
Efficiency Ratios
Cost to Income Ratio 38.39% 39.43% 39.02% 39.30%
Business per Employee (in INR mn) 177.40 155.80 157.48 154.38
Profit per Employee (in INR mn) 2.10 2.00 2.04 1.97
Valuation Ratios
P/E 11.81 9.22 11.30 9.53
P/ABV 2.65 2.10 1.94 1.68
Dividend Yield 1.40% 1.93% 1.68% 2.05%
*As per Basel III, hence not comparable to previous years
4
BFSI
Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited
(hereinafter referred as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should
not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis
for an investment decision. The intent of this document is not in recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to
all the views expressed therein The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon
such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information
contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or
consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or employees do not provide,
at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness
for a particular purpose, and non-infringement.
The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned
in this report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
Disclosure of Interest Statement
1. Analyst ownership of the stock - No
2. Group/Directors ownership of the stock - No
3. Broking relationship with company covered - No
This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time.
Nevertheless, SPA is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries.
SPA Securities Ltd SEBI Reg. Nos.
NSE Cash INB231178238
NSE Future & Option INF231173238
NSE Currency Derivatives INE231178238
BSE Cash INB011178234
BSE Currency Derivatives INE011178234
MCX-SX Cash INB261178231
MCX-SX Future & Option INF261178231
MCX-SX Currency Derivatives INE261178238
USE Currency Derivatives INE271178234
Mutual Fund ARN 77388
OTCEI INB200891838
PMS INP000003179
CDSL DP IN-DP-CDSL-485-2008
NSDL DP IN-DP-NSDL-316-2009
SPACAPITALSERVICES LIMITED
Investment Advisory Services,
AMFI Reg. No. ARN-0007
SPACAPITALADVISORS LIMITED
SEBI registered Category-1
Merchant Bankers
SEBI Regn. No. INM000010825
SPACOMTRADE PRIVATE LIMITED
Member of NCDEX & MCX.
NCDEX TMID-00729,
NCDEX FMC No.NCDEX/TCM/CORP/0714
SPAINSURANCEBROKINGSERVICESLTD
Direct Broker for Life and General
Insurance Broking
IRDA Lic. Code No. DB053/03
For More Information Visit Us At : www.spasecurities.com
Sharad Avasthi Dy Head - Equity Research sharad.avasthi@spagroupindia.com Tel.: +91-33-4011 4800 Ext.832
SPA Securities Ltd: Mittal Court, A-Wing, 10th Floor, Nariman Point, Mumbai - 400 021, Tel. No. : +91-022-4289 5600, Fax: +91 (22) 2657 3708/9

More Related Content

What's hot

IS Investment 1H15 Results & Performance Presentation
IS Investment 1H15  Results & Performance PresentationIS Investment 1H15  Results & Performance Presentation
IS Investment 1H15 Results & Performance Presentationİş Yatırım
 
Q1 2013 investor presentation
Q1 2013 investor presentationQ1 2013 investor presentation
Q1 2013 investor presentationnexon-ir
 
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...Alliance Bank Malaysia Berhad
 
Financial services banking
Financial services bankingFinancial services banking
Financial services bankingSourav Mishra
 
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 financial results, fundamental, accumulate, analysis, investment, CMP, targe... financial results, fundamental, accumulate, analysis, investment, CMP, targe...
financial results, fundamental, accumulate, analysis, investment, CMP, targe...IndiaNotes.com
 
Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15lcchong76
 
General Motors Versus GB Auto Financial Comparison
General Motors Versus GB Auto Financial ComparisonGeneral Motors Versus GB Auto Financial Comparison
General Motors Versus GB Auto Financial ComparisonMenatallah Abdel Azeem
 
Bangladesh Private Commercial Banks Quarterly Overview - November 2011
Bangladesh Private Commercial Banks Quarterly Overview - November 2011Bangladesh Private Commercial Banks Quarterly Overview - November 2011
Bangladesh Private Commercial Banks Quarterly Overview - November 2011The Growth Institute
 
ICICI Prudential Growth Fund - Series 1 (Presentation)
ICICI Prudential Growth Fund - Series 1 (Presentation)ICICI Prudential Growth Fund - Series 1 (Presentation)
ICICI Prudential Growth Fund - Series 1 (Presentation)iciciprumf
 
4863682 financial-analysis-on-annual-report-on-two-company
4863682 financial-analysis-on-annual-report-on-two-company4863682 financial-analysis-on-annual-report-on-two-company
4863682 financial-analysis-on-annual-report-on-two-companycapechore
 
Axis Bank Q1FY15: NIMs largely stable; Buy
 Axis Bank Q1FY15: NIMs largely stable; Buy Axis Bank Q1FY15: NIMs largely stable; Buy
Axis Bank Q1FY15: NIMs largely stable; BuyIndiaNotes.com
 
IDFC Dynamic Equity Fund_Fund spotlight
IDFC Dynamic Equity Fund_Fund spotlightIDFC Dynamic Equity Fund_Fund spotlight
IDFC Dynamic Equity Fund_Fund spotlightIDFCJUBI
 
Value investing for klse market
Value investing for klse marketValue investing for klse market
Value investing for klse marketlcchong76
 
Torrent i sec (1)
Torrent i sec (1)Torrent i sec (1)
Torrent i sec (1)Jigar Savla
 
Security Analysis of Astra Microwave Company
Security Analysis of Astra Microwave CompanySecurity Analysis of Astra Microwave Company
Security Analysis of Astra Microwave CompanyPRIYAJNVCTC
 
Banking Sector Q4FY15 preview: Asset quality will remain under pressure
Banking Sector Q4FY15 preview: Asset quality will remain under pressureBanking Sector Q4FY15 preview: Asset quality will remain under pressure
Banking Sector Q4FY15 preview: Asset quality will remain under pressureIndiaNotes.com
 

What's hot (20)

IS Investment 1H15 Results & Performance Presentation
IS Investment 1H15  Results & Performance PresentationIS Investment 1H15  Results & Performance Presentation
IS Investment 1H15 Results & Performance Presentation
 
Q1 2013 investor presentation
Q1 2013 investor presentationQ1 2013 investor presentation
Q1 2013 investor presentation
 
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...
9M FY2015 Results Analyst Briefing as at 31 December 2014 from Alliance Finan...
 
Financial services banking
Financial services bankingFinancial services banking
Financial services banking
 
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 financial results, fundamental, accumulate, analysis, investment, CMP, targe... financial results, fundamental, accumulate, analysis, investment, CMP, targe...
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 
Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15
 
Half Year Analyst Briefing as at 30 September 2013
Half Year Analyst Briefing as at 30 September 2013Half Year Analyst Briefing as at 30 September 2013
Half Year Analyst Briefing as at 30 September 2013
 
General Motors Versus GB Auto Financial Comparison
General Motors Versus GB Auto Financial ComparisonGeneral Motors Versus GB Auto Financial Comparison
General Motors Versus GB Auto Financial Comparison
 
Bangladesh Private Commercial Banks Quarterly Overview - November 2011
Bangladesh Private Commercial Banks Quarterly Overview - November 2011Bangladesh Private Commercial Banks Quarterly Overview - November 2011
Bangladesh Private Commercial Banks Quarterly Overview - November 2011
 
Portfolio magtppt
Portfolio magtpptPortfolio magtppt
Portfolio magtppt
 
ICICI Prudential Growth Fund - Series 1 (Presentation)
ICICI Prudential Growth Fund - Series 1 (Presentation)ICICI Prudential Growth Fund - Series 1 (Presentation)
ICICI Prudential Growth Fund - Series 1 (Presentation)
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
4863682 financial-analysis-on-annual-report-on-two-company
4863682 financial-analysis-on-annual-report-on-two-company4863682 financial-analysis-on-annual-report-on-two-company
4863682 financial-analysis-on-annual-report-on-two-company
 
Itc sec1
Itc sec1Itc sec1
Itc sec1
 
Axis Bank Q1FY15: NIMs largely stable; Buy
 Axis Bank Q1FY15: NIMs largely stable; Buy Axis Bank Q1FY15: NIMs largely stable; Buy
Axis Bank Q1FY15: NIMs largely stable; Buy
 
IDFC Dynamic Equity Fund_Fund spotlight
IDFC Dynamic Equity Fund_Fund spotlightIDFC Dynamic Equity Fund_Fund spotlight
IDFC Dynamic Equity Fund_Fund spotlight
 
Value investing for klse market
Value investing for klse marketValue investing for klse market
Value investing for klse market
 
Torrent i sec (1)
Torrent i sec (1)Torrent i sec (1)
Torrent i sec (1)
 
Security Analysis of Astra Microwave Company
Security Analysis of Astra Microwave CompanySecurity Analysis of Astra Microwave Company
Security Analysis of Astra Microwave Company
 
Banking Sector Q4FY15 preview: Asset quality will remain under pressure
Banking Sector Q4FY15 preview: Asset quality will remain under pressureBanking Sector Q4FY15 preview: Asset quality will remain under pressure
Banking Sector Q4FY15 preview: Asset quality will remain under pressure
 

Viewers also liked

HDFC overtakes Yes Bank and ICICI in June 2014
HDFC overtakes Yes Bank and ICICI in June 2014HDFC overtakes Yes Bank and ICICI in June 2014
HDFC overtakes Yes Bank and ICICI in June 2014Simplify360
 
29037262 yes-bank-project-report
29037262 yes-bank-project-report29037262 yes-bank-project-report
29037262 yes-bank-project-reportVaibhav .
 
Volatility in indian stock market and foreign institutional investor
Volatility in indian stock market and foreign institutional investorVolatility in indian stock market and foreign institutional investor
Volatility in indian stock market and foreign institutional investorPranjal Chopda
 
A project report on awareness level of personal banking products of SBI bank
A project report on awareness level of personal banking products of SBI bankA project report on awareness level of personal banking products of SBI bank
A project report on awareness level of personal banking products of SBI bankBabasab Patil
 
Yes bank success story
Yes bank success storyYes bank success story
Yes bank success storyVijay Tayade
 
Demand forecast of hospitals in india
Demand forecast of hospitals in indiaDemand forecast of hospitals in india
Demand forecast of hospitals in indiaManoj Kumar
 
Comparative Analysis of Axis Bank with other Banks
Comparative Analysis of Axis Bank with other BanksComparative Analysis of Axis Bank with other Banks
Comparative Analysis of Axis Bank with other BanksLairenlakpam Mangal
 
HDFC BANK PROJECT REPORT
HDFC BANK PROJECT REPORTHDFC BANK PROJECT REPORT
HDFC BANK PROJECT REPORTAbhishek Keshri
 

Viewers also liked (12)

HDFC overtakes Yes Bank and ICICI in June 2014
HDFC overtakes Yes Bank and ICICI in June 2014HDFC overtakes Yes Bank and ICICI in June 2014
HDFC overtakes Yes Bank and ICICI in June 2014
 
Swot analysis on yes bank
Swot analysis on yes bankSwot analysis on yes bank
Swot analysis on yes bank
 
29037262 yes-bank-project-report
29037262 yes-bank-project-report29037262 yes-bank-project-report
29037262 yes-bank-project-report
 
Volatility in indian stock market and foreign institutional investor
Volatility in indian stock market and foreign institutional investorVolatility in indian stock market and foreign institutional investor
Volatility in indian stock market and foreign institutional investor
 
A project report on awareness level of personal banking products of SBI bank
A project report on awareness level of personal banking products of SBI bankA project report on awareness level of personal banking products of SBI bank
A project report on awareness level of personal banking products of SBI bank
 
Yes bank
Yes bank Yes bank
Yes bank
 
YES BANK ANALYSIS
YES BANK ANALYSISYES BANK ANALYSIS
YES BANK ANALYSIS
 
Yes bank success story
Yes bank success storyYes bank success story
Yes bank success story
 
Demand forecast of hospitals in india
Demand forecast of hospitals in indiaDemand forecast of hospitals in india
Demand forecast of hospitals in india
 
Strategic analysis of hdfc bank
Strategic analysis of hdfc bankStrategic analysis of hdfc bank
Strategic analysis of hdfc bank
 
Comparative Analysis of Axis Bank with other Banks
Comparative Analysis of Axis Bank with other BanksComparative Analysis of Axis Bank with other Banks
Comparative Analysis of Axis Bank with other Banks
 
HDFC BANK PROJECT REPORT
HDFC BANK PROJECT REPORTHDFC BANK PROJECT REPORT
HDFC BANK PROJECT REPORT
 

Similar to Yes Bank: Reports tepid set of numbers in Q1FY15; Hold

QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA Securities
QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA SecuritiesQFY14: Allahabad Bank continues to report tepid sets of numbers - SPA Securities
QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA SecuritiesIndiaNotes.com
 
ING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralIndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangIndiaNotes.com
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndiaNotes.com
 
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal BangIndiaNotes.com
 
AxisBank‬ Ltd.Q2 FY16 Result Analysis
AxisBank‬ Ltd.Q2 FY16 Result AnalysisAxisBank‬ Ltd.Q2 FY16 Result Analysis
AxisBank‬ Ltd.Q2 FY16 Result Analysischoice broking
 
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15IndiaNotes.com
 
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 LIC Housing Finance Q1FY15: Buy for a target of Rs332 LIC Housing Finance Q1FY15: Buy for a target of Rs332
LIC Housing Finance Q1FY15: Buy for a target of Rs332IndiaNotes.com
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQIndiaNotes.com
 
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15IndiaNotes.com
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceIndiaNotes.com
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; HoldIndiaNotes.com
 
Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165IndiaNotes.com
 
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'IndiaNotes.com
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic PharmaIndiaNotes.com
 
Liberty Bank Research Note - Q1 2014 Results
Liberty Bank Research Note - Q1 2014 ResultsLiberty Bank Research Note - Q1 2014 Results
Liberty Bank Research Note - Q1 2014 ResultsLiberty Securities
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 

Similar to Yes Bank: Reports tepid set of numbers in Q1FY15; Hold (20)

QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA Securities
QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA SecuritiesQFY14: Allahabad Bank continues to report tepid sets of numbers - SPA Securities
QFY14: Allahabad Bank continues to report tepid sets of numbers - SPA Securities
 
ING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutral
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
 
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra &amp; Mahindra Financial Services - Nirmal Bang
 
AxisBank‬ Ltd.Q2 FY16 Result Analysis
AxisBank‬ Ltd.Q2 FY16 Result AnalysisAxisBank‬ Ltd.Q2 FY16 Result Analysis
AxisBank‬ Ltd.Q2 FY16 Result Analysis
 
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
 
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 LIC Housing Finance Q1FY15: Buy for a target of Rs332 LIC Housing Finance Q1FY15: Buy for a target of Rs332
LIC Housing Finance Q1FY15: Buy for a target of Rs332
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
 
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15
Canara Bank: Slippages rise q-o-q to Rs26bn during Q1FY15
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165
 
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'
HDFC Bank result update: Q4FY15 PAT up 21% YoY, Motilal Oswal maintains 'Buy'
 
Half Year Analyst Briefing as at 30 September 2014
Half Year Analyst Briefing as at 30 September 2014Half Year Analyst Briefing as at 30 September 2014
Half Year Analyst Briefing as at 30 September 2014
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 
Liberty Bank Research Note - Q1 2014 Results
Liberty Bank Research Note - Q1 2014 ResultsLiberty Bank Research Note - Q1 2014 Results
Liberty Bank Research Note - Q1 2014 Results
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNotes.com
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 

Recently uploaded

Stock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfStock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfMichael Silva
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdfHenry Tapper
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfHenry Tapper
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxhiddenlevers
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办fqiuho152
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...Suhani Kapoor
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawlmakika9823
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...shivangimorya083
 
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...ranjana rawat
 
Chapter 2.ppt of macroeconomics by mankiw 9th edition
Chapter 2.ppt of macroeconomics by mankiw 9th editionChapter 2.ppt of macroeconomics by mankiw 9th edition
Chapter 2.ppt of macroeconomics by mankiw 9th editionMuhammadHusnain82237
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...Henry Tapper
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managmentfactical
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Sapana Sha
 
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一S SDS
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spiritegoetzinger
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...Suhani Kapoor
 

Recently uploaded (20)

Stock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfStock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdf
 
fca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdffca-bsps-decision-letter-redacted (1).pdf
fca-bsps-decision-letter-redacted (1).pdf
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
 
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
 
Chapter 2.ppt of macroeconomics by mankiw 9th edition
Chapter 2.ppt of macroeconomics by mankiw 9th editionChapter 2.ppt of macroeconomics by mankiw 9th edition
Chapter 2.ppt of macroeconomics by mankiw 9th edition
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
SBP-Market-Operations and market managment
SBP-Market-Operations and market managmentSBP-Market-Operations and market managment
SBP-Market-Operations and market managment
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
 
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road🔝+919953056974 🔝young Delhi Escort service Pusa Road
🔝+919953056974 🔝young Delhi Escort service Pusa Road
 
Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spirit
 
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
VIP High Class Call Girls Saharanpur Anushka 8250192130 Independent Escort Se...
 

Yes Bank: Reports tepid set of numbers in Q1FY15; Hold

  • 1. 1 BFSI Yes Bank Yes Bank reported tepid set of numbers which were marginally below our estimates. While NII grew by 13.1% YoY to INR 7453 mn, profit grew by 9.6% to INR 4395 mn dented largely by 3.7% decline in non interest income and 25.1% surge in operating expenses (driven by advertisement expenses of ~INR 230 mn relating to IPL sponsorship). Asset quality continued to remain robust with PCR of 78.4% and loan impaired ratio of mere 0.52%, which is amongst the best in the industry. We change our rating from BUY to HOLD on the stock with a target of INR 572. Corporate banking driving advances Advances grew by 23.2% to INR 590 bn led by 31.6% surge in Corporatebankingsegment (contribution+440bpsto68.7%).Retail bankingsegmentcontributing16.8%alsoclockedagrowthof23.2% YoY to INR 99 bn. The bank remained cautious in lending to mid- sized corporate as advances in this segment declined by 4.0%. The customerassetsgrewby16.4%(<20%forfourthconsecutivequarter) to INR 713 bn due to slower traction in credit substitute segment, proportion of which declined by 454 bps to 17.3%. We expect the loan book to grow at 21.4% CAGR over FY14-16E. Traction in CASA continues CASA traction continued with CASA ratio improving by 213 bps to 22.3% driven by 1.4x increase in savings deposits. Additionally YBL has started focusing on retail CA to drive CA deposits and has added 200-250 retail CA sales force. Overall deposits grew by 16.6% to INR 761 bn led by 29.0% surge in CASA deposit to INR 170 bn. Increasing traction in savings deposits coupled with increasing branch penetration and renewed focus towards building retail liability franchise would aid YBL to improve its CASA ratio by ~1- 1.5% each quarter. We expect deposit to grow at 16.6% CAGR over FY14-16E driven by 29.9% CAGR in CASA deposits, resulting CASA ratio of 27.3% in FY16. NIMs flat at 3.0% NIMs remained flat at 3.0% as both yields on advances & cost of funds increased sequentially by 10 bps each to 12.5% & 8.5% respectively in Q1FY15. We expect NIMs to improve by over 10 bps led by improvement in yields (supported by recent capital issuance) and moderating cost of funds (on the back of improving CASA ratio and expected softening in wholesale rates). Decline in Non-Interest income after 14 quarters NOI declined by 3.7% (for the first time after 14 quarters) to INR 4256 mn largely owing to one time monetization of bond gains Shareholding (%) Jun-14 Promoters 22.22 FIIs 45.60 DIIs 20.44 Others 11.74 Relative Prince Performance July 24, 2014 RESULTUPDATE-Q1FY15 amounting to INR 950 mn amidst favorable debt market environment in Q1FY14. Transaction banking segment reported a growth of 59.0% to INR 1402 mn on the back of enhanced cross selling of products to customers. Retail banking fees segment grew 43.8% to INR 525 mn albeit on a low base, which is in line with its strategy of building granularity in fee income. Growth in Financial advisory segment improved by 37.5% to INR 1975 mn. Financial Market segment bore the brunt as it declined sharply by 79.7% owing to INR 450 mn loss on swap position taken in earlier quarters to protect the investment portfolio against a rise in interest rates. Asset quality continues to remain robust Asset quality remained among the best in the industry with impaired loan ratio of mere 0.52% largely owing to its stringent risk management system. Restructured book stood at INR 1131 mn (0.19% of advances). Slippages, recoveries/upgrades and write-offs stood at INR 1150 mn, INR 820 mn and INR 100 mn respectively. Strong PCR of 78.1% in addition to countercyclical buffer of INR 2.4 bn (0.4% of advances) provides comfort of asset quality front. Outlook & Valuation YBL is one of our preferred plays in private banking sector due to its expanding corporate book, strengthening balance sheet, diversified fee income and superlative return ratios. Its strategy of shifting product mix in favour of high yielding segments coupled with continued traction in CASA deposit mobilization will drive the growth of YBL. Best asset quality in the industry coupled with loan impaired ratio of mere 0.52% provides addition comfort. Recent capital raising in addition to expected economic revival lends comfort to banks valuation. We change our rating from BUY to HOLD on the stock with a target of INR 572, which implies 1.79x FY16E P/ABV. Key Data BSE Code 532648 NSE Code YESBANK Bloomberg Code YES IN Reuters Code YESB.BO Shares O/S (mn) 415.20 Face Value 10 Mcap (INR bn) 222.82 52 Week H/L 588.00/216.10 2W Avg. Qty, NSE 3721561 Free Float (INR bn) 173.31 Beta 2.43 Y/E March (INR mn) FY13 FY14 FY15E FY16E Interest income 82940 99814 113024 133005 Interest Expended 60752 72651 81674 94912 Net interest income 22188 27163 31350 38093 Growth (%) 37.33% 22.42% 15.41% 21.51% NIM (%) 2.85% 2.91% 3.01% 3.13% APAT 13007 16178 19720 23369 Growth (%) 33.06% 24.34% 21.89% 18.50% EPS (INR) 36.28 44.86 47.50 56.28 P/E 11.81 9.22 11.30 9.53 P/ABV 2.65 2.10 1.94 1.68 Net NPA 0.01% 0.05% 0.07% 0.06% RoA 1.51% 1.55% 1.66% 1.67% RoE 24.82% 25.03% 21.14% 18.81% Dividend Yield 1.40% 1.93% 1.68% 2.05% Sensex: 26147 CMP:INR537 Target: INR 572 Rohit Agarwal rohit.agarwal@spagroupindia.com Ph. No. 91 33 40114800/ 839 40 60 80 100 120 140 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Jan-14 Feb-14 Mar-14 Apr-14 May-14 Jun-14 Jul-14 Yes Bank Sensex
  • 2. 2 BFSI Other Highlights • C/I ratio has deteriorated sequentially by 338 bps to 45.0% owing to higher advertisement cost relating to IPL sponsorship amounting to INR 230 mn and muted growth in income. • Provision during the quarter stood at INR 237 mn. Break-up - a) INR 400 mn for standard assets - INR 210 mn for general loss & INR 190 mn for unhedged forex currency exposure as per RBI guidelines (YBL has assessed clients to unhedged foreign currency at INR 760 mn overall, which it has spread over four quarters of FY15. This is however expected to decline as actual unhedged forex will likely be lower), b) INR 120 mn as counter cyclical buffer provisions, c) INR 180 mn for NPAs and d) write back of INR 460 mn of investment depreciation (Rates have decline in Q1 and hence losses have reversed) • CAR has improved to 18.0% with Tier I being at 12.6% post recent capital issuance of $ 500 mn, which will aid in maintaining growth for next couple of years. Quarterly Financials Particulars(INRmn) Q1FY15 Q4FY14 Q3FY14 Q2FY14 Q1FY14 YoY% QoQ% InterestIncome 26796 25681 25141 25013 23979 11.75% 4.34% InterestExpenses 19343 18485 18487 18292 17388 11.24% 4.64% NetInterestIncome 7453 7196 6655 6721 6591 13.08% 3.58% NetInterestMargin(%) 3.00 3.00 2.90 2.90 3.00 - - OtherIncome 4256 4455 3879 4461 4421 -3.72% -4.47% TotalIncome 11710 11651 10533 11182 11012 6.34% 0.50% TotalOperatingExpenses 5267 4847 4387 4053 4212 25.05% 8.68% EmployeeExpenses 2247 2038 1941 1853 2012 11.71% 10.25% Otheroperatingexpenses 3020 2808 2446 2200 2200 37.25% 7.53% OperatingProfit 6442 6804 6147 7129 6800 -5.25% -5.32% CosttoIncomeRatio(%) 44.98% 41.60% 41.64% 36.25% 38.25% (673bps) (338bps) Provisions&Contingencies 237 723 133 1791 970 -75.52% -67.16% ProvisionforTaxes 1810 1779 1858 1626 1821 -0.61% 1.73% NetProfit 4395 4302 4156 3711 4008 9.64% 2.15% EPS 10.60 11.93 11.53 10.30 11.14 -4.90% -11.17% Equity 4147 3606 3606 3604 3597 15.29% 15.00% GNPA 1980 1749 1958 1321 1049 88.68% 13.17% NNPA 428 261 423 194 121 254.39% 64.21% %GNPA 0.33 0.31 0.39 0.28 0.22 11bps 2bps %NNPA 0.07 0.05 0.08 0.04 0.03 4bps 2bps RoA(Annualised) 1.60 1.60 1.60 1.50 1.60 - - Source:Company, SPA Research De-regulation proving to be game changer 10.1% 10.4% 11.2% 12.6% 12.5% 20.2% 20.4% 20.9% 22.0% 22.3% 0% 5% 10% 15% 20% 25% Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Saving Deposit CASA Ratio NIMsrecouping back to 3% 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% Q4FY13 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 2.8% 2.9% 3.0% 3.1% CoF YoA NIM Well-distributed fee franchise 39.3% 40.3% 18.2% 12.1% 8.3% 32.4% 27.8% 42.0% 39.5% 46.4% 8.2% 11.6% 11.4% 12.3% 19.9% 20.3% 28.4% 30.0% 32.9% 18.3% 0% 20% 40% 60% 80% 100% 120% Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Financial Markets Financial Advisory Retail Banking Transaction Banking Best asset qualityin the industry 0.22 0.28 0.33 0.03 0.04 0.08 0.05 0.07 0.39 0.31 0.00 0.10 0.20 0.30 0.40 0.50 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 GNPA (%) NNPA (%)
  • 3. 3 BFSI Financials Income StatementY Y/E March (INR mn) FY13 FY14 FY15E FY16E Interest income 82940 99814 113024 133005 Growth (%) 31.50% 20.34% 13.24% 17.68% Interest Expended 60752 72651 81674 94912 Net interest income 22188 27163 31350 38093 Growth (%) 37.33% 22.42% 15.41% 21.51% Other Income 12574 17216 21520 25393 Net Income 34762 44378 52869 63487 Operating Expenditure 13345 17499 20628 24951 Operating Income 21417 26880 32241 38535 Provisions & Contingencies 2160 3617 3453 4169 PBT 19257 23263 28789 34366 Tax 6251 7085 9068 10997 PAT 13007 16178 19720 23369 APAT 13007 16178 19720 23369 Growth (%) 33.06% 24.34% 21.89% 18.50% EPS (INR) 36.28 44.86 47.50 56.28 Balance Sheet Y/E March (INR mn) FY13 FY14 FY15E FY16E SOURCES OF FUNDS Equity Share Capital 3586 3606 4152 4152 Reserves 54491 67611 111239 128911 Total Shareholders Funds 58077 71217 115391 133063 Total Deposits 669556 741920 851724 1009293 Growth (%) 36.22% 10.81% 14.80% 18.50% Borrowings 209222 213143 245114 294137 Other Liabilities & Provisions 54187 63878 70265 73779 Total Liabilities 991041 1090158 1282495 1510272 APPLICATION OF FUNDS Current Assets 40658 58917 95805 123020 Investments 429760 409504 450454 495499 Advances 469996 556330 667596 819807 Growth (%) 23.72% 18.37% 20.00% 22.80% Fixed Assets 2295 2935 3043 3069 Other Assets 48332 62473 65597 68877 Total Assets 991041 1090158 1282495 1510272 Key Ratios Y/E March (INR mn) FY13 FY14 FY15E FY16E Per Share Data (INR) EPS 36.28 44.86 47.50 56.28 BVPS 161.94 197.48 277.92 320.48 ABVPS 161.75 196.76 276.87 319.26 DPS 6.00 8.00 9.00 11.00 Profitability Ratios Yield on Advances 12.79% 12.80% 12.82% 12.86% Cost of Deposits 10.46% 10.29% 10.25% 10.20% Net Interest Margin 2.85% 2.91% 3.01% 3.13% RoA 1.51% 1.55% 1.66% 1.67% RoE 24.82% 25.03% 21.14% 18.81% Balance Sheet Ratios Credit/Deposit Ratio 70.20% 74.99% 78.38% 81.23% Investment/Deposit Ratio 64.19% 55.20% 52.89% 49.09% CASA Ratio 18.95% 22.03% 25.91% 27.33% Capital Adequacy Ratio (CAR) 18.30% 14.40%* 17.40% 16.30% Tier I 9.50% 9.80% 11.30% 10.20% Aseet Quality Ratios Gross NPA 0.20% 0.31% 0.39% 0.43% Net NPA 0.01% 0.05% 0.07% 0.06% Provision Coverage Ratio 92.60% 85.10% 85.86% 82.43% Slippage Ratio 0.57% 0.78% 0.85% 0.82% Efficiency Ratios Cost to Income Ratio 38.39% 39.43% 39.02% 39.30% Business per Employee (in INR mn) 177.40 155.80 157.48 154.38 Profit per Employee (in INR mn) 2.10 2.00 2.04 1.97 Valuation Ratios P/E 11.81 9.22 11.30 9.53 P/ABV 2.65 2.10 1.94 1.68 Dividend Yield 1.40% 1.93% 1.68% 2.05% *As per Basel III, hence not comparable to previous years
  • 4. 4 BFSI Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited (hereinafter referred as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The intent of this document is not in recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to all the views expressed therein The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock - No 2. Group/Directors ownership of the stock - No 3. Broking relationship with company covered - No This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time. Nevertheless, SPA is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. SPA Securities Ltd SEBI Reg. Nos. NSE Cash INB231178238 NSE Future & Option INF231173238 NSE Currency Derivatives INE231178238 BSE Cash INB011178234 BSE Currency Derivatives INE011178234 MCX-SX Cash INB261178231 MCX-SX Future & Option INF261178231 MCX-SX Currency Derivatives INE261178238 USE Currency Derivatives INE271178234 Mutual Fund ARN 77388 OTCEI INB200891838 PMS INP000003179 CDSL DP IN-DP-CDSL-485-2008 NSDL DP IN-DP-NSDL-316-2009 SPACAPITALSERVICES LIMITED Investment Advisory Services, AMFI Reg. No. ARN-0007 SPACAPITALADVISORS LIMITED SEBI registered Category-1 Merchant Bankers SEBI Regn. No. INM000010825 SPACOMTRADE PRIVATE LIMITED Member of NCDEX & MCX. NCDEX TMID-00729, NCDEX FMC No.NCDEX/TCM/CORP/0714 SPAINSURANCEBROKINGSERVICESLTD Direct Broker for Life and General Insurance Broking IRDA Lic. Code No. DB053/03 For More Information Visit Us At : www.spasecurities.com Sharad Avasthi Dy Head - Equity Research sharad.avasthi@spagroupindia.com Tel.: +91-33-4011 4800 Ext.832 SPA Securities Ltd: Mittal Court, A-Wing, 10th Floor, Nariman Point, Mumbai - 400 021, Tel. No. : +91-022-4289 5600, Fax: +91 (22) 2657 3708/9